Literature DB >> 12378741

The altruistic medical researcher: gone and forgotten?

H P von Schroeder1.   

Abstract

With increasing economic, political, and bureaucratic involvement in research, there is little focus on the medical researcher's idealistic and benevolent intentions. Benevolence is a pillar of ethical human-subjects research, and altruism is a form of benevolence that is difficult to quantify. It is interest in the welfare of others without personal benefit. This article examines the extent of altruism in medical research from philosophical, psychological, and practical points of view. With the emergence of experimental human trials in the first half of the century, the fame and recognition of physicians largely precluded altruistic motivation. From the philosophical perspective, altruism is at best an optional moral principle. It is not evident in ethical guidelines. In the scientific process, altruism can exist only in ethical and properly designed research. Egoism, scientific misconduct, and conflicts of interest undermine it; but altruism is also a potential solution for these problems. Research is not globally oriented and has an unjust distribution. In an evolutionary model, altruism cannot thrive due to its lack of rewards and feedback, particularly in the economic climate of today's science. Anonymity is decreasing, selfishness is increasing. Research has become an industry, and virtuous ideals are a romantic notion. If we use altruism as an indicator, then its rarity and fragility indicate research's unhealthy state.

Entities:  

Keywords:  Bioethics and Professional Ethics; Biomedical and Behavioral Research

Mesh:

Year:  1997        PMID: 12378741

Source DB:  PubMed          Journal:  Ann R Coll Physicians Surg Can        ISSN: 0035-8800


  2 in total

1.  The not-for-profit form and translational research: Kerr revisited?

Authors:  Keith A Joiner
Journal:  J Transl Med       Date:  2005-04-29       Impact factor: 5.531

Review 2.  The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.

Authors:  C Norman Coleman; Silvia C Formenti; Tim R Williams; Daniel G Petereit; Khee C Soo; John Wong; Nelson Chao; Lawrence N Shulman; Surbhi Grover; Ian Magrath; Stephen Hahn; Fei-Fei Liu; Theodore DeWeese; Samir N Khleif; Michael Steinberg; Lawrence Roth; David A Pistenmaa; Richard R Love; Majid Mohiuddin; Bhadrasain Vikram
Journal:  Front Oncol       Date:  2014-11-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.